Filing Details
- Accession Number:
- 0001104659-22-062766
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-19 10:21:00
- Reporting Period:
- 2022-05-17
- Accepted Time:
- 2022-05-19 10:21:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1875558 | Nuvectis Pharma Inc. | NVCT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1251213 | Ron Bentsur | C/O Nuvectis Pharma, Inc., 1 Bridge Plaza, Suite 275 Fort Lee NJ 07024 | Chairman & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-17 | 200 | $19.77 | 2,959,604 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-17 | 110 | $20.83 | 2,959,714 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-18 | 700 | $20.60 | 2,960,414 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-18 | 1,000 | $18.49 | 2,961,414 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Reflects the weighted average purchase price. The range of prices for the shares purchased was $19.75 to $19.79. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- Includes 96,759 shares of restricted stock and 120,000 restricted stock units.
- Reflects the weighted average purchase price. The range of prices for the shares purchased was $20.10 to $20.82. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- Reflects the weighted average purchase price. The range of prices for the shares purchased was $18.45 to $18.50. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
